Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Aclarion, Inc.

  • BROOMFIELD, Colorado
  • Public · NASDAQ: ACON
  • 11 employees
$8.8MMarket cap
$75.7KRevenue · FY2025
-$7.2MNet income
11Employees
ACONNASDAQ
2022IPO

About Aclarion, Inc.

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$75.7K
Net income
-$7.2M
Total assets
$13.7M
Market cap
$8.8M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: ACON

15-minute delayed · data by Polygon.io

Market cap
$8.8M
Open
Day range
Prev close
Volume
IPO date
Apr 22, 2022

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Aclarion, Inc..

Write a review
Explore

Similar companies

Browse all →